MEN-B (Xenova)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMEN-B (Xenova)
Drug Alias Namemeningitis vaccine (Cantab)meningitis B vaccine (Xenova)meningococcal B vaccine (Xenova)MEN-B
ClassificationVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMeningococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCantab Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCantab BiopharmaceuticalsXenova Group Ltd
Active IndicationsN/A
Inactive IndicationsMeningococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A